The subthalamic nucleus (STN) plays a pivotal role in normal and abnormal motor function. We used patch pipettes to study effects of 5-hydroxytryptamine (5HT) on synaptic currents evoked in STN neurons by focal electrical stimulation of rat brain slices. 5HT (10 μM) reduced glutamatemediated excitatory postsynaptic currents (EPSCs) by 35 ± 4%. However, a much higher concentration of 5HT (100 μM) was required to inhibit GABA-mediated inhibitory postsynaptic currents (IPSCs) to a comparable extent. Concentration-response curves showed that the 5HT IC 50 for inhibition of IPSCs (20.2 μM) was more than 5-fold greater than the IC 50 for inhibition of EPSCs (3.4 μM). The 5HT-induced reductions in EPSCs and IPSCs were accompanied by increases in paired-pulse ratios, indicating that 5HT acts presynaptically to inhibit synaptic transmission. The 5HT1B receptor antagonist NAS-181 significantly antagonized 5HT-induced inhibitions of EPSCs and IPSCs. These studies show that 5HT inhibits synaptic transmission in the STN by activating presynaptic 5HT 1B receptors.Keywords presynaptic inhibition; EPSC; IPSC; 5-hydroxytryptamine; serotonin; brain slice; patch clampThe subthalamic nucleus (STN) is a basal ganglia structure comprised of glutamate-containing neurons that project to the two output nuclei of the basal ganglia: substantia nigra pars reticulata and globus pallidus interna (Albin et al., 1995). By way of its glutamatergic projections, the STN plays an important role in normal and pathological motor behaviors. For example, excessive burst firing of STN neurons is thought to contribute to the akinesia of Parkinson's disease (Benedetti et al., 2004;Wichmann et al., 1994). The importance of the STN in the control of movement is also evidenced by the effective therapeutic effects of surgical lesions in an animal model of Parkinson's disease (Bergman et al., 1990) and high frequency STN stimulation in Parkinson's disease patients (Krack et al., 1998).Among the neurotransmitter systems that regulate STN neuronal activity, the actions of 5-hydroxytryptamine (5HT) have yet to be fully investigated. The STN receives a dense 5HT-containing innervation that arises from the dorsal raphe nucleus (Canteras et al., 1990;Mori et al., 1985). Furthermore, the STN has been shown to express several 5HT receptor subtypes, * Author for correspondence: Steven W, Johnson, MD, PhD, Portland VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, OR 97207 USA, Section Editor: Dr. Yoland Smith (neuropharmacology) Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. (Pompeiano et al., 1994;W...